Interleukin-3 (IL-3)-dependent mouse myeloid 32DC13 cells differentiate to neutrophils in response to granulocyte colony-stimulating factor (G-CSF). Introduction of the human c-fms gene, which encodes the receptor for CSF-1, into 32DC13 cells gave rise to variants that were able to proliferate in medium containing either 'murine IL-3 or human recombinant CSF-1, but were unable to differentiate to granulocytes in response to G-CSF. Unlike parental 32CD13 cells, CSF-1 -responsive derivatives expressed nonspecific esterase when grown in CSF-1, but did not exhibit many other morphologic, immunologic, or functional properties of mononuclear phagocyte differentiation, or express murine CSF-1 receptors. Accelerated turnover of the OMMITMENT OF immature myeloid cells to differen-C tiate within the granulocyte and mononuclear phagocyte lineages is accompanied by alterations in expression of receptors for different hematopoietic growth factors. Immature cells that respond to pluripoietins such as interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) become progressively more sensitive to the actions of the lineage-specific growth factors, G-CSF, and M-CSF or CSF-1, as they mature within the granulocyte or macrophage lineages, respectively.' Expression of the CSF-1 receptor (CSF-1R) is first detected in mononuclear phagocyte precursors and increases as the cells whereas such cells exhibit reduced responsiveness to GM-CSF and
human CSF-1 receptor was observed in response to CSF-1 and phorbol esters, but not after stimulation with IL-3 or bacterial lipopolysaccharide. Although both CSF-1 and IL-3 induced tyrosine phosphorylation of heterologous substrates in the dually responsive cells, differences in the patterns of substrate phosphorylation were observed in response to the two hematopoietins. We conclude that expression of the human CSF-1 receptor in 32DC13 cells not only induces CSF-1 responsiveness, but alters its phenotype in a way that prohibits granulocyte differentiation. 0 1990 by The American Society of Hematology.
sets of genes that independently contribute to each of these activities. In support of this hypothesis, the effects of CSF-1 on cell proliferation and survival can be dissociated, since submitogenic doses of CSF-1 can maintain the viability of nonproliferating bone marrow-derived macrophages that become growth arrested in the early GI phase of the cell cycle. lo^' '
An unresolved issue concerns the extent to which the CSF-1R tyrosine kinase modulates the activity of genes that determine different stages of mononuclear phagocyte differentiation. To approach this problem in a model system, we introduced c-fms cDNA encoding human CSF-1R1' into mouse 32DC13 cells, which self-renew in IL-3 but terminally differentiate to neutrophils in response to G-CSF.13s'4 Populations of CSF-1 R-bearing cells were obtained that proliferated in either IL-3 or CSF-1, expressed monocyte esterases, and failed to differentiate in response to G-CSF. Our results suggest that CSF-1R both positively and negatively regulates the expression of gene products affecting differentiation within the monocyte and granulocyte lineages.
MATERIALS AND METHODS

IL-3dependent 32DC13
cell^'^.'^ and CSF-ldependent BACl.2F5 macrophages" were generously provided by Dr Giovanni Rovera (Wistar Institute, Philadelphia, PA) and Dr E. Richard Stanley (Albert Einstein College of Medicine, Bronx, NY), respectively. The cells were maintained in Iscove's medium containing 20% fetal calf serum (HyClone, Logan, UT), glutamine, antibiotics, and requisite growth factors (either 20% Wehi-3B cell conditioned medium as a source of IL-3 or 25% L-cell conditioned medium as a source of murine CSF-1). The human glioblastoma cell line, U87 MG, also provided by Dr Giovanni Rovera, was grown in complete Iscove's medium without other growth factors and was used as a source of G-CSF. I6 A BamHI fragment containing the intact human c-fms cDNA" was inserted in both the sense and antisense orientation into an inducible expression vector'' containing four tandem upstream copies of a metal response element,19 the &globin TATA box 5' of the BamHI cloning site, and a simian virus 40 polyadenylation signal downstream of the inserted gene. The c-fms plasmids were each electroporatedl' into 32DC13 cells with a second plasmid (pSV2ne0)~' that confers resistance to the antibiotic G418 (Geneticin, Sigma Chemicals, St Louis, MO). Electroporated cells were seeded at 3 x REPROGRAMMING THE CSF-1 RESPONSE 1781 for 3 weeks in complete medium containing IL-3 and 800 pg/mL G418. The medium was then supplemented with heavy metals
(1 x IO-, mol/L ZnSO, and 5 x IO-' mol/L CdSO,), and selection was continued in the presence of IL-3 and G418 for 2 more weeks.
Equal aliquots of cells from G418-resistant cultures electroporated with the c-fms gene in sense orientation were pooled, and cells expressing human CSF-1 R were selected by fluorescence-activated cell sorting using a monoclonal antibody (MoAb) to the human receptor." The sorted CSF-1R-positive population (designated 32D[R+] cells) was maintained in medium containing IL-3. In parallel, cells from each independent culture were grown in complete medium supplemented with 2,000 U/mL (0.9 nmol/L) of human recombinant CSF-1. Seven cultures yielding CSF-1-responsive cells were obtained, three of which (designated 32D[R+]Cl.l, C1.2, and C1.3) were characterized in detail.
Other analytical methods. Cells in suspension culture were concentrated on slides by cytocentrifugation, fixed in cold 9.25% formalin, 45% acetone in sodium phosphate buffer, pH 6.6, and stained for 1 hour at room temperature in an esterase reaction mixture (pH 6.3) containing 50 pg/mL a-naphthyl butyrate as a substrate.,, In some reactions, 1.25 mg/mL sodium fluoride was added to the reaction mixture to inhibit nonspecific esterase activity. Procedures for metabolic labeling with [35S]methionine, cell lysis, immunoprecipitation, polyacrylamide gel electraphore~is,~' and immunoblotting with antiserum to phosphotyrosineZ4 are described in detail in the references cited.
Special biologic reagents. Purified murine IL-3 was supplied by Dr James Ihle (St Jude Children's Research Hospital, Memphis, TN) and human recombinant CSF-I was obtained from Dr Steven Clark (Genetics Institute, Cambridge, MA). 12-0-tetradecanoylphorbol-13-acetate (TPA), bacterial lipopolysaccharide (LPS), prostaglandin E, (PGE,), 5-azacytidine (all from Sigma Chemicals), 1,25-dihydroxyvitamin D3, and leukotriene B4 (LTB4) (both from Biomol Research Laboratories, Plymouth Meeting, PA), and mouse recombinant GM-CSF (Genzyme Corp, Boston, MA) were obtainedfrom the indicated vendors. Production of MoAbs to human CSF-1R2' and affinity-purified rabbit antibodies to phosphotyrosineZ4 was described previously.
An NcoI fragment (nucleotides 2271 to 3280)" representing the 3' end of the human c-fms gene, was inserted into a pBR322-based expression plasmid, P S J H~~, ,~ after conversion of its unique ClaI and BamHI cloning sites into NcoI and XhoI sites, respectively.26 The resultant construct contained the X pL promoter, and coded for a thermoinducible X C,,-c-fms fusion protein of 37.5 Kd containing the carboxylterminal 340 amino acids of human CSF-1R. The plasmid was inserted into Escherichia coli strain N4830, which contains a thermolabile pL repressor. After culture at 42OC, the induced fusion protein was purified by differential salt fractionation and electrophoresis on denaturing gels, and the eluted polypeptide was used to immunize rabbits." The resulting antiserum to human CSF-1R crossreacts with both murine CSF-IR and the feline v-fms oncogene product, and supports their kinase activities in in vitro enzyme assays performed with immune complexes.
Preparation of rabbit antiserum to CSF-IR.
RESULTS
Transduction of human CSF-IR into IL-3-responsive 32DC13 cells. The mouse myeloid cell line, 32DC13, is dependent on IL-3 for proliferation and survival, but terminally differentiates into mature granulocytes when IL-3 is removed from the culture medium and is replaced by G-CSF.",I4 To determine whether 32DC13 cells could be reprogrammed to proliferate in CSF-1 and whether stimulation by CSF-1 would affect their pattern of differentiation, we introduced the human c-fms gene encoding CSF-1R into these cells and tested their response to different hematopoietins.
Human c-fms cDNA, cloned into an inducible expression vector containing a metal-responsive enhancer fused to the P-globin promoter,'* was electroporated into 32DC13 cells with pSV2ne0, a plasmid that confers resistance to the antibiotic G418.*' The electroporated cells were then divided at 3 x lo5 cells per culture into a 24-well multiplate and grown for 3 weeks in medium containing IL-3 and G418. Twenty-one G418-resistant cultures were obtained and passaged for 2 additional weeks in medium containing IL-3 and heavy metals to induce expression of human CSF-1R. Equal For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From 1782 KAT0 AND SHERR IL-3 for survival and proliferation, but died in the absence of either factor. When these CSF-1-responsive cell lines were analyzed by FACS for expression of human CSF-lR, they expressed significantly higher levels of the receptor than pooled 32D[R+] cells grown in IL-3 (Fig 1) . These levels of CSF-1R are equivalent to those detected on murine BAC1.2F5 macrophages (about 1 x lo5 CSF-1 binding sites/cell). Although the experimental protocol prohibited an estimation of their frequency, the results suggested that only those cells that expressed high levels of human CSF-1 R selectively grew out in response to CSF-1. Cells from the one factor-independent culture also exhibited very high levels of CSF-1R expression (data not shown), consistent with previous results suggesting that overexpression of CSF-1 R in immature myeloid cells may contribute to a factor-independent phenotype. '8 Growth in response to murine IL-3, human CSF-1, or in medium containing both growth factors, but died in the absence of either. Although human CSF-1 can bind with high affinity to both human and mouse CSF-lR, murine CSF-1 does not bind to human CSF-1R or induce the growth of cells bearing the human
As expected, murine CSF-1 did not support the growth or survival of 32D[R+]Cl.l cells, implying that they did not express murine CSF-1R (see below) and that their growth in response to human CSF-1 was mediated by the transduced c-fms gene product.
When washed and transferred to medium containing G-CSF, 32DC13 cells eventually stopped growing (Fig 2A) and differentiated to granulocytes. Figure 3 contrasts the morphology of the parental cells maintained in IL-3 (A) with those cultured for 10 days in G-CSF (B) and illustrates the conversion of immature myeloid cells to more mature granulocytes containing banded or segmented nuclei.14 In contrast, the survival of CSF-1-responsive 32D[R+]Cl.1 cells was not supported by G-CSF (Fig 2B) . Although these cells could be maintained for a somewhat longer period of time in medium containing G-CSF than in unsupplemented medium, no viable cells remained after 10 days of G-CSF treatment. Moreover, no morphologic evidence of granulocytic differentiation was observed in G-CSF-treated 32D[R+]Cl.l, C1.2, or C1.3 cultures maintained during this period, nor did G-CSF inhibit their growth in response to either IL-3 or CSF-1 (data not shown).
Because the CSF-1-responsive cell lines were unable to differentiate to granulocytes in response to G-CSF, we considered the possibility that CSF-1 induced an alternative genetic program leading toward monocytic maturation. Therefore, the cells were assayed for production of nonspecific esterases as markers of monocytic differentiation. The term nonspecific esterase is reserved for enzymes capable of hydrolyzing simple esters of N-free alcohols and organic acids. For those enzymes that use a-naphthyl butyrate as a substrate, the reaction products are generally confined to monocytes.22 Parental 32DC13 cells lacked this activity (Fig  3A) , as did those that had been induced to differentiate to granulocytes (Fig 3B) . CSF-1R-positive 32D[R+] cells that had never been cultured in CSF-1 contained occasional nonspecific esterase-positive cells (Fig 3C) , whereas 32D[R+]Cl.l cells maintained in human CSF-1 exhibited high levels of enzymatic activity (Fig 3D) . When the latter cells were washed, resuspended, and cultured for 2 more weeks in medium containing IL-3, the cells remained highly esterase-positive (Fig 3E) , suggesting that induction of this activity by CSF-1 was not readily reversible. The enzyme was completely inhibited by addition of sodium fluoride to the reaction buffer (Fig 3F) , providing further evidence that it represented a monocytic isoform. 22 Although the CSF-1-responsive cell lines were esterasepositive, they lacked many other features of monocytic differentiation. The cells remained nonadherent, were nonphagocytic, could not present antigens to their respective T-cell hybridomas, were unable to support an antibodydependent cytotoxic response to sheep erythrocytes, and expressed only low levels of the MAC-1 antigen3' equivalent to those detected on parental 32DC13 cells (negative data Cl.l cells were metabolically labeled with ["S]methionine, and human CSF-I R was immunoprecipitated from detergent lysates using an MoAb that does not crossreact with murine CSF-I R." The cleared lysates were then reacted with a polyvalent rabbit antiserum raised to a human c-fms polypeptide that crossreacts with the murine receptor. As a positive control. lysates of metabolically labeled murine BAC I .2F5 macrophages. which express high levels of the mouse CSF-I receptor."'." were analyzed in parallel. All immunoprecipitates were denatured and *parated on polyacrylamide gels containing sodium dodecyl sulfate, and receptors were detected by autoradiography of the dried slab gels. Under these labeling conditions. both the immature intracellular form (about 130 Kd) and mature cell surface form (about 165 Kd) of CSF-IR are detected; the two forms differ solely in their composition of asparaginelinked oligosaccharide chains.' Figure 4 (lanes I and 5 ) shows that parental 32DC13 cells did not express CSF-1 R. As expacted from FACS analysis (Fig I) . medium containing human recombinant CSF-1, expressed significantly more CSF-1R than cells passaged in IL-3, as judged both by FACS analysis and by biosynthetic labeling studies. Thus, only those transformants expressing high levels of human CSF-1 R appeared to have had a proliferative advantage when the cells were shifted to medium containing CSF-1. In FDC-P1 cells, high levels of human CSF-1R expression were also associated with the emergence of factor-independent variants, which depended on CSF-1R-mediated signals for ce1lgrowth.l8 Incontrast, 32D[R+]Cl.l, C 1.2, and C 1.3 cells remained factor-dependent throughout months of continuous passage in culture, as did single-cell subclones derived from them, and only one factor-independent cell line was obtained. Based on the elevated basal levels of receptor tryosine phosphorylation observed in these cells, we presume that CSF-1R kinase activity can provide certain variants with a selective growth advantage, even in the absence of ligand.
Because 32D [ R + ] C 1.1 cells remained dually responsive to IL-3 and CSF-1, we were able to examine whether IL-3 treatment transmodulated the CSF-1 receptor by inducing its accelerated degradation. We considered this possibility because IL-3 treatment at 37OC can induce the rapid loss of CSF-1 binding sites from normal mouse bone marrow cells by an as yet ill-defined me~hanism.~' Although phorbol esters and other inducers of protein kinase C can transmodulate CSF-1R by activating a protease that cleaves the receptor near its membrane-spanning segment,34 IL-3 treatment had no effect on CSF-1R turnover in 32D[R+]Cl.l cells. Reciprocally, insertion of the constitutively active v-fms oncogene into FDC-P1 cells, although able to confer factor-independence, did not affect the number or affinity of IL-3 binding sites expressed at the cell surface.31 TPA transmodulated CSF-1R in both 32D[R+]Cl.l and BACl.2F5 cells, but LPS induced CSF-1R turnover only in BAC1.2F5 macrophages. This implies that LPS does not mediate its effects by directly activating protein kinase C, but rather, its active moiety (lipid A) may bind to another receptor that is differentially expressed in these two cell types.
Although the mechanisms of signal transduction by the IL-3 receptor remain unclear, IL-3 has been shown to bind to a 140-Kd cell surface glycoprotein and to stimulate its phosphorylation on tyrosine residues.36 After stimulation of 32D[R+]Cl.l cells with IL-3, immunoblotting analyses performed with antibodies to phosphotyrosine showed the presence of a 140-Kd substrate as well as a second major tyrosine phosphorylated species of 95 Kd. One or both of these proteins might well represent components of the IL-3 receptor or, alternatively, substrates of an IL-3 receptorassociated tyrosine kinase. CSF-1 treatment of the same cells induced the appearance of different tyrosine phosphorylated substrates, including human CSF-1R itself. However, like IL-3, CSF-1 induced tyrosine phosphorylation of a 95-Kd protein. Apart from their molecular masses, we have no further biochemical evidence that the 95-Kd phosphoproteins observed in response to IL-3 and CSF-1 represent the identical polypeptide. Therefore, although direct transmodulation of CSF-1R by IL-3 was not observed, our results do not preclude "crosstalk" between the two receptor signaling pathways.
